VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CYTK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CYTKCytokinetics, Incorporated
$87.26$10.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCYTKQuarterly Financials

Cytokinetics, Incorporated (CYTK) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Cytokinetics, Incorporated (CYTK) quarterly income statement — complete revenue, gross profit & net income history

CYTK Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue19.36M17.75M1.94M66.77M1.58M16.93M463K249K835K1.67M378K867K4.61M1.96M2.52M88.97M1.15M55.6M5.44M2.84M
Revenue Growth %1125.78%4.89%318.14%26714.86%89.1%912.38%22.49%-71.28%-81.9%-14.56%-84.97%-99.03%301.83%-96.48%-53.74%3029.37%-82.47%727.13%-86.96%-20.87%
Cost of Goods Sold2.39M2.86M2.68M2.29M99.84M93.63M84.61M79.6M81.57M84.98M82.53M83.19M79.42M75.02M62.73M57.13M45.94M43.5M48.44M36.44M
COGS % of Revenue12.36%16.11%138.38%3.42%6323.05%553.13%18274.73%31966.67%9768.86%5082.3%21833.86%9595.62%1721.68%3833.32%2494.39%64.21%4001.31%78.23%890.86%1281.85%
Gross Profit16.96M14.89M-743K64.48M-98.26M-76.7M-84.15M-79.35M-80.73M-83.3M-82.15M-82.33M-74.81M-73.06M-60.22M31.84M-44.79M12.1M-43M-33.6M
Gross Margin %87.64%83.89%-38.38%96.58%-6223.05%-453.13%-18174.73%-31866.67%-9668.86%-4982.3%-21733.86%-9495.62%-1621.68%-3733.32%-2394.39%35.79%-3901.31%21.77%-790.86%-1181.85%
Gross Profit Growth %117.26%119.42%99.12%181.27%-21.71%7.93%-2.43%3.62%-7.92%-14.02%-36.43%-358.55%-67.03%-703.71%-40.05%194.77%-79.05%153.79%-345.91%-84.65%
Operating Expenses200.58M193.26M166.01M175.99M57.37M62.34M56.65M50.82M45.5M44.11M40.11M39.72M49.66M53.97M48.22M42.72M33.07M33.81M26.2M21.2M
OpEx % of Revenue1036.33%1088.48%8575%263.58%3633.25%368.28%12235.85%20411.24%5449.1%2638.4%10611.38%4581.55%1076.63%2757.74%1917.38%48.01%2880.66%60.8%481.92%745.59%
Selling, General & Admin104.9M91.72M69.46M65.72M57.37M62.34M56.65M50.82M45.5M44.11M40.11M39.72M49.66M53.97M48.22M42.72M33.07M33.81M26.2M21.2M
SG&A % of Revenue541.96%516.6%3587.71%98.43%3633.25%368.28%12235.85%20411.24%5449.1%2638.4%10611.38%4581.55%1076.63%2757.74%1917.38%48.01%2880.66%60.8%481.92%745.59%
Research & Development95.53M101.54M99.23M112.55M99.84M93.63M84.61M79.6M81.57M84.98M82.53M83.19M79.42M75.02M62.73M57.13M45.94M43.5M48.44M36.44M
R&D % of Revenue493.54%571.88%5125.67%168.57%6323.05%553.13%18274.73%31966.67%9768.86%5082.3%21833.86%9595.62%1721.68%3833.32%2494.39%64.21%4001.31%78.23%890.86%1281.85%
Other Operating Expenses160K0-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-183.62M-178.37M-166.75M-111.51M-155.63M-139.04M-140.8M-130.17M-126.23M-127.42M-122.27M-122.05M-124.47M-127.03M-108.44M-10.87M-77.86M-21.7M-69.2M-54.8M
Operating Margin %-948.69%-1004.6%-8613.38%-167%-9856.3%-821.41%-30410.58%-52277.91%-15117.96%-7620.69%-32345.24%-14077.16%-2698.31%-6491.06%-4311.77%-12.22%-6781.97%-39.04%-1272.78%-1927.44%
Operating Income Growth %-17.98%-28.28%-18.43%14.34%-23.29%-9.12%-15.16%-6.66%-1.42%-0.31%-12.75%-1022.39%-59.87%-485.28%-56.7%80.16%-91.71%40.39%-1434.9%-69.35%
EBITDA-183.62M-175.69M-164.08M-109.22M-153.33M-136.66M-138.39M-127.77M-123.9M-121.08M-120.41M-119.26M-121.69M-124.29M-106.35M-8.87M-76.29M-19.02M-68.74M-54.25M
EBITDA Margin %-948.69%-989.51%-8475%-163.58%-9710.64%-807.33%-29889.85%-51311.65%-14838.8%-7241.81%-31854.76%-13755.25%-2637.98%-6351%-4228.75%-9.97%-6645.38%-34.2%-1264.28%-1908.34%
EBITDA Growth %-19.75%-28.56%-18.56%14.51%-23.75%-12.86%-14.93%-7.13%-1.82%2.58%-13.22%-1244.21%-59.51%-553.6%-54.72%83.65%-90.37%47.08%-1301.73%-69.85%
D&A (Non-Cash Add-back)02.68M2.68M2.29M2.3M2.38M2.41M2.41M2.33M6.33M1.85M2.79M2.78M2.74M2.09M2M1.57M2.69M462K543K
EBIT-183.62M-183.03M-279.86M-110.11M-138.43M-127.43M-138.25M-119.02M-118.32M-119.83M-115.43M-115.27M-118.05M-121.11M-126.54M-10.01M-80.14M-22.08M-68.97M-54.61M
Net Interest Income0-18.86M-16.07M-11.26M-9.24M-7.58M-5.24M-12.75M-9.41M-9.48M-7.16M-6.59M-6.82M-10.35M-11.62M-8.95M-8.89M-8.87M-6.88M-6.76M
Interest Income011.47M10.25M13M13.7M15.01M17.05M11.55M7.91M7.59M6.84M6.78M6.42M5.92M4.14M864K415K0231K187K
Interest Expense-14.52M30.34M26.32M24.27M22.95M22.59M22.3M24.3M17.32M17.06M14M13.37M13.24M16.27M15.77M9.81M9.31M8.87M7.12M6.94M
Other Income/Expense-22.41M-4.67M-139.42M-22.86M-5.75M-10.98M-19.74M-13.15M-9.41M-9.48M-7.16M-6.59M-6.82M-10.35M-33.87M-8.95M-11.59M-8.87M-6.88M-6.76M
Pretax Income-206.03M-183.03M-306.18M-134.37M-161.38M-150.02M-160.54M-143.32M-135.64M-136.9M-129.42M-128.64M-131.29M-137.38M-142.31M-19.82M-89.44M-30.57M-76.09M-61.55M
Pretax Margin %-1064.48%-1030.87%-15814.98%-201.25%-10220.14%-886.28%-34674.95%-57557.43%-16244.67%-8187.56%-34238.62%-14837.02%-2846.07%-7019.93%-5658.45%-22.28%-7791.38%-54.98%-1399.41%-2165.11%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-206.03M-183.03M-306.18M-134.37M-161.38M-150.02M-160.54M-143.32M-135.64M-136.9M-129.42M-128.64M-131.29M-137.38M-142.31M-19.82M-89.44M-30.57M-76.09M-61.55M
Net Margin %-1064.48%-1030.87%-15814.98%-201.25%-10220.14%-886.28%-34674.95%-57557.43%-16244.67%-8187.56%-34238.62%-14837.02%-2846.07%-7019.93%-5658.45%-22.28%-7791.38%-54.98%-1399.41%-2165.11%
Net Income Growth %-27.67%-22%-90.71%6.24%-18.97%-9.59%-24.05%-11.41%-3.32%0.35%9.06%-549.03%-46.78%-349.39%-87.04%67.8%-89.89%30.41%-2296.41%-50.94%
Net Income (Continuing)-206.03M-183.03M-306.18M-134.37M-161.38M-150.02M-160.54M-143.32M-135.64M-136.9M-129.42M-128.64M-131.29M-137.38M-142.31M-19.82M-89.44M-30.57M-76.09M-61.55M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.67-1.50-2.55-1.12-1.36-1.27-1.36-1.31-1.33-1.38-1.35-1.34-1.36-1.39-1.88-0.34-1.19-0.36-0.95-0.86
EPS Growth %-22.79%-18.11%-87.5%14.5%-2.26%7.97%-0.74%2.24%2.21%0.72%28.19%-294.12%-14.29%-286.11%-97.89%60.47%-80.3%41.94%-1943.01%-26.47%
EPS (Basic)-1.67-1.49-2.55-1.12-1.36-1.27-1.36-1.31-1.33-1.38-1.35-1.34-1.36-1.39-1.88-0.34-1.19-0.36-0.95-0.86
Diluted Shares Outstanding123.27M122.43M119.98M119.46M118.5M118.08M117.69M109.24M101.92M99.07M96.07M95.75M95.16M94.68M93.76M85.73M85M84.09M80.33M71.75M
Basic Shares Outstanding123.27M122.02M119.98M119.46M118.5M118.08M117.69M109.24M101.92M99.07M96.07M95.75M95.16M94.68M93.76M85.73M85M83.86M80.09M71.75M
Dividend Payout Ratio--------------------